October 2003

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-10-02-2003, Volume 27, Issue 10

Pharmaceutical science & technology news.

Related Content:

Industry NewsQuality SystemsPharmaceutical Technology-10-02-2003
FDA Warns of Rare but Serious Drug Reaction to Antiseizure Medicines
Novartis Voluntarily Recalls Two Lots of Sandimmune Oral Solution, 100 mg/mL
New Medicines, Markets, and Manufacture: CRISPR for Sickle Cell Disease and β-thalassemia